The Effects Upon Haemopoiesis of Prolonged Intra-Arterial Infusions of Methotrexate Combined with the Intermittent Administration of Folinic Acid with Observations on the Plasma Levels and Urinary Excretion of Methotrexate
1964

Effects of Methotrexate on Blood Cell Production

Sample size: 14 publication Evidence: moderate

Author Information

Author(s): D. P. Rose, M. R. Bond, Christine Evans

Primary Institution: University Department of Surgery and The Department of Haematology, The Royal Infirmary, Sheffield

Hypothesis

How do prolonged intra-arterial infusions of Methotrexate combined with folinic acid affect blood cell production?

Conclusion

The study found that high levels of Methotrexate can reach the bone marrow, leading to changes in blood cell production despite the administration of folinic acid.

Supporting Evidence

  • Eight of the 14 patients showed a fall in haemoglobin levels greater than 2 g per 100 ml.
  • Nine patients developed leucopenia within 3 days of the end of infusion.
  • Four patients had reduced serum folic acid levels before infusion.

Takeaway

Doctors gave a medicine called Methotrexate to help treat cancer, and they found it affected how the body makes blood cells, even when they tried to protect the body with another medicine.

Methodology

Patients received continuous intra-arterial infusions of Methotrexate and intermittent intramuscular injections of folinic acid, with blood tests conducted to monitor changes.

Limitations

The study had a small sample size and variability in patient responses to Methotrexate.

Participant Demographics

Patients had locally advanced malignant disease in the head and neck region, pelvis, or lower limbs, with a mix of genders and ages ranging from 40 to 67.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication